OpenAI unveils GPT-Rosalind, a reasoning model aimed at drug discovery and genomics

OpenAI introduced GPT-Rosalind on April 16, 2026, a frontier reasoning model aimed at drug discovery, genomics analysis, protein reasoning, and scientific research workflows. The release extends the company’s model lineup into a more specialized scientific use case.

By |2026-04-21T02:18:24+00:00April 21, 2026|News|Comments Off on OpenAI unveils GPT-Rosalind, a reasoning model aimed at drug discovery and genomics

OpenAI launches safety fellowship as it broadens outside research push

OpenAI on April 6 announced a new Safety Fellowship for external researchers, engineers and practitioners focused on advanced AI safety and alignment work. The pilot adds another layer to the company’s push to expand

By |2026-04-13T00:35:00+00:00April 10, 2026|News|Comments Off on OpenAI launches safety fellowship as it broadens outside research push
Go to Top